Digirad

Executive Summary

Digirad is a US-based medical technology company specializing in solid-state nuclear imaging cameras for cardiology and nuclear medicine. Founded in 1994, the company offers diagnostic imaging solutions and comprehensive support services on an as-needed basis. With a focus on convenience and efficiency, Digirad serves healthcare providers looking for flexible diagnostic imaging options. As a private company with limited public disclosures, its growth trajectory is driven by service contracts and potential product innovations in the nuclear imaging space. The diagnostics imaging market is experiencing steady demand, driven by an aging population and increasing prevalence of cardiovascular diseases. Digirad's solid-state technology differentiates it from traditional cameras by offering improved image quality and lower maintenance. While the company operates in a niche segment, its as-needed service model provides recurring revenue opportunities. Key challenges include competition from larger imaging firms and the need for continued technological investment. Overall, Digirad is positioned for steady but moderate growth, subject to market adoption and strategic execution.

Upcoming Catalysts (preview)

• Q4 2026Launch of Next-Generation Solid-State Camera50% success
• Q3 2026Expansion of Service Contracts with Hospital Systems70% success
• Q2 2027Strategic Partnership for Distribution in Europe40% success